Saturday - July 12, 2025
FDA Sets Regulatory Review Period for TriReme Medical's Chocolate Touch Drug-Coated Balloon Catheter
July 07, 2025
WASHINGTON, July 7 (TNSFR) -- The U.S. Department of Health and Human Services Food and Drug Administration has determined the regulatory review period for the Chocolate Touch, a Paclitaxel drug coated percutaneous transluminal angioplasty balloon catheter developed by TriReme Medical LLC.

This device, designed for PTA of femoral or popliteal arteries, underwent a rigorous review process before earning FDA approval for commercial use.

According to the notice published i . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products